Sign in
4

Changes in Ownership

Viridian Therapeutics, Inc.\DE Filed Acc 0001193125-26-359636

Chief Legal Officer sold 14,212 shares at $24.50 ($348,194)

  • Chief Legal Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tousignant Jennifer Chief Legal Officer 2026-08-19 Sale −4,212 $24.50 $103,194 0 D
Tousignant Jennifer Chief Legal Officer 2026-08-19 Option exercise +10,000 $14.41 $144,100 10,000 D
Tousignant Jennifer Chief Legal Officer 2026-08-19 Sale −10,000 $24.50 $245,000 0 D
Derivatives
Tousignant Jennifer Chief Legal Officer 2026-08-19 Option exercise · Stock Option (Right to Buy) −10,000 114,072 D
Open-market sales · 14,212 sh · avg $24.50 · $348,194
Loading xslF345X06/ownership.xml…